SoundThinking Introduces Generative AI-Powered Search Capabilities for CrimeTracer

4 minutes ago
GlobeNewswire

Summary: SoundThinking expands its AI offerings with the introduction of generative AI chatbot technology in CrimeTracer, enabling law enforcement to…

Correction: Form 8.3 – Warehouse REIT Plc

11 minutes ago

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of…

SKL’D Redefines Skilled Trades and Supply Chain Staffing in Atlanta

18 minutes ago

Industry Veterans Launch Specialized Staffing Company Focused on Workforce Development and Strategic PartnershipsATLANTA, April 24, 2025 (GLOBE NEWSWIRE) -- SKL’D,…

CERo Therapeutics Holdings, Inc. Announces Sarah Cannon Research Institute at Colorado Blood Cancer Institute as Key Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia

19 minutes ago

SOUTH SAN FRANSCISCO, Calif, April 24, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”)…

Le Vian Unveils Exclusive Emerald Ombré™ Collection at Jared Jewelers

21 minutes ago

A Mesmerizing Gradient of Emerald Hues A selection of Le Vian's Emerald Ombrè™ rings, only at Jared Celebrating the Natural…

S&P Global agrees to acquire ORBCOMM’s Automatic Identification System business, strengthening its supply chain and maritime offerings

29 minutes ago

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- S&P Global (NYSE: SPGI) today announced an agreement to acquire the Automatic…

Stellantis and Factorial Energy Reach Key Milestone in Solid-State Battery Development

33 minutes ago

Stellantis and Factorial Energy Reach Key Milestone in Solid-State Battery Development Stellantis and Factorial Energy successfully validated automotive-sized solid-state battery…

Independent Bank Corporation Reports 2025 First Quarter Results

34 minutes ago

First Quarter Highlights Highlights for the first quarter of 2025 include: Increase in net interest income of $0.8 million (or…

NephroDI Therapeutics’ Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology

34 minutes ago

April 25, 2025, Seattle, WA – NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder…

This website uses cookies.